| Scorecard |
|---|
|
2 / 5 Stars
|
|
Lipper
1
2
4
1
5
|
|
Zacks Investment Research
2
(Buy)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
C+
(Hold)
|
Fund Holdings
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 2.95 | 2.95 |
| Stocks | 86.19 | 86.19 |
| Bonds | 0.0 | 0.0 |
| Other | 0.02 | 0.02 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 10.84 | 10.84 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Target Corp | TGT | 19.82 | 2.53 |
| Pfizer Inc | PFE | 16.19 | 2.52 |
| Exxon Mobil Corporation | XOM | 1.77 | 2.51 |
| Microsoft Corporation | MSFT | 23.36 | 2.5 |
| Royal Dutch Shell PLC ADR Class A | RDS.A | -0.77 | 2.47 |
| GlaxoSmithKline PLC ADR | GSK | 20.06 | 2.46 |
| Directv | DTV | 12.94 | 2.37 |
| Capital One Financial Corp | COF | -0.91 | 2.34 |
| PNC Financial Services Group Inc | PNC | 16.64 | 2.33 |
| E.I. du Pont de Nemours & Company | DD | 19.61 | 2.28 |
